DKP
CITE

Davidson Kempner Partners’s Cartica Acquisition Corp Class A Ordinary Shares CITE Stock Holding History

Davidson Kempner Partners’s Portfolio CITE Stock Details CITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$3.69M Buy
+350,000
New +$3.66M 0.07% 179

Other funds holding CITE

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Davidson Kempner Partners's CITE Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Cartica Acquisition Corp Class A Ordinary Shares (CITE) in Q1 2023: 350,000 shares worth $3.69M. The stake represents 0.07% of the portfolio and ranks #179 among its holdings.

58 funds tracked by Wall St. Rank hold CITE as of Q1 2023.

  • Davidson Kempner Partners held 350,000 shares of Cartica Acquisition Corp Class A Ordinary Shares worth $3.69M as of Q1 2023.
  • Cartica Acquisition Corp Class A Ordinary Shares was a new Davidson Kempner Partners position in Q1 2023.
  • Cartica Acquisition Corp Class A Ordinary Shares made up 0.07% of Davidson Kempner Partners's portfolio in Q1 2023, its #179 holding.
  • 58 funds tracked by Wall St. Rank held Cartica Acquisition Corp Class A Ordinary Shares as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.